Revelation Biosciences (REVB) vs Sunshine Biopharma (SBFM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Revelation Biosciences is the larger company by market cap ($3.1 million vs $1.8 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | REVB | SBFM |
|---|---|---|
| Share price | $0.77 | $0.4175 |
| Market cap | $3.07M | $1.80M |
| 1-day change | -7.02% | -40.36% |
| P/E ratio (TTM) | 0.17 | — |
| Forward P/E | — | 0.00 |
| EPS (TTM) | $4.60 | $-9.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.24 | $24.30 |
| 52-week low | $0.75 | $0.356 |
| Distance from 52-week high | -87.66% | -98.28% |
| Average volume | 39.03K | 3.33M |
| Shares outstanding | 3.98M | 4.31M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
REVB vs SBFM FAQ
Which is bigger, Revelation Biosciences or Sunshine Biopharma?
Revelation Biosciences (REVB) is larger, with a market capitalization of $3.07M compared with $1.80M for Sunshine Biopharma (SBFM).
Are Revelation Biosciences and Sunshine Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.